AGÕæÈ˹ٷ½

STOCK TITAN

Privia Health Group, Inc. SEC Filings

PRVA NASDAQ

Welcome to our dedicated page for Privia Health Group SEC filings (Ticker: PRVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Pinpointing payer-mix risks, capitated revenue shifts, or physician-count growth inside Privia Health’s SEC reports can feel like decoding medical jargon. The company’s value-based care contracts, risk-sharing models, and reimbursement disclosures span hundreds of pages—meaning critical insights are easy to miss.

Stock Titan’s AI-powered engine turns that complexity into clarity. Need the latest Privia Health quarterly earnings report 10-Q filing or an alert the moment a doctor-led executive sells shares? Our platform streams every Form straight from EDGAR, then delivers plain-English explanations. From Privia Health insider trading Form 4 transactions to a Privia Health 8-K material events explained summary, you’ll see what moved the stock and why—without wading through dense text.

Here’s what you can accomplish in minutes:

  • Track Privia Health Form 4 insider transactions real-time and monitor physician-executive buying trends.
  • Dive into a Privia Health annual report 10-K simplified view that surfaces capitated revenue percentages, CMS dependence, and segment margins.
  • Receive concise Privia Health earnings report filing analysis that links revenue swings to patient-panel growth.
  • Compare incentive structures through the Privia Health proxy statement executive compensation breakdown.

Whether you’re understanding Privia Health SEC documents with AI for the first time or need quick context before a trade, our real-time updates and expert notes keep you ahead. Complex disclosures, now clear.

Rhea-AI Summary

Privia Health Group (PRVA) filed an 8-K (Item 5.02) announcing a governance change. Effective July 15, 2025, the Board will expand from nine to ten seats and elect Lance Berberian as a Class III independent director. He will also join the Audit Committee and meets Nasdaq’s heightened independence, financial sophistication and literacy standards.

Under the company’s Non-Employee Director Compensation Program, Mr. Berberian will receive a standard annual cash retainer (amount not disclosed) and an equity award of restricted stock units valued at $200,000, pro-rated for his first partial term. The company states there are no related-party transactions and no special arrangements behind his selection. A confirming press release (Exhibit 99.1) was issued on July 8, 2025.

The filing is purely a corporate governance update; no operational, financial or strategic guidance is provided. While the addition of an independent, audit-qualified director should strengthen oversight and align with best-practice governance, the event is unlikely to have a material near-term financial impact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
current report

FAQ

What is the current stock price of Privia Health Group (PRVA)?

The current stock price of Privia Health Group (PRVA) is $21.1 as of July 10, 2025.

What is the market cap of Privia Health Group (PRVA)?

The market cap of Privia Health Group (PRVA) is approximately 2.7B.

What is the core business of Privia Health Group, Inc.?

Privia Health Group, Inc. is primarily a technology-driven physician enablement company that partners with medical groups, health plans, and health systems to improve practice operations and patient care.

How does Privia Health generate revenue?

The company generates revenue by maintaining partnerships that optimize physician performance and efficiencies in healthcare delivery, leveraging cloud-based technology and integrated operational services.

What role does technology play in Privia Health's operations?

Technology is central to Privia Health’s model; its cloud-based platform facilitates seamless data integration, operational streamlining, and real-time analytics, all of which support improved patient outcomes and administrative efficiency.

How does Privia Health contribute to value-based care?

By aligning its services with evidence-based practices and incentivizing high-quality care, Privia Health supports value-based care models that focus on reducing unnecessary costs and improving patient satisfaction.

What differentiates Privia Health from its competitors?

Privia Health differentiates itself through its integrated platform that combines advanced technology with operational support, fostering a collaborative environment that addresses both the clinical and administrative challenges of modern healthcare.

What kind of partnerships does Privia Health engage in?

The company collaborates with a wide range of healthcare stakeholders, including medical groups, health plans, and health systems, to design and implement solutions that enhance operational efficiency and care quality.

In what ways does Privia Health optimize healthcare delivery?

Privia Health optimizes healthcare delivery by streamlining revenue cycle management, improving data integration, and leveraging cloud-based systems to reduce inefficiencies and support evidence-based care practices.

How is Privia Health recognized in the healthcare industry?

The company has received recognition for its excellence in revenue cycle management and operational efficiency, reflecting its dedication to enhancing healthcare practices and supporting the shift towards holistic, patient-centered care.
Privia Health Group, Inc.

NASDAQ:PRVA

PRVA Rankings

PRVA Stock Data

2.67B
113.74M
10.6%
102.34%
3.44%
Health Information Services
Services-health Services
United States
ARLINGTON